ENST00000849709.1:n.824A>G

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The ENST00000849709.1(POLR1HASP):​n.824A>G variant causes a non coding transcript exon change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.319 in 151,656 control chromosomes in the GnomAD database, including 7,963 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.32 ( 7963 hom., cov: 31)

Consequence

POLR1HASP
ENST00000849709.1 non_coding_transcript_exon

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: -0.369

Publications

15 publications found
Variant links:
Genes affected
HLA-A (HGNC:4931): (major histocompatibility complex, class I, A) HLA-A belongs to the HLA class I heavy chain paralogues. This class I molecule is a heterodimer consisting of a heavy chain and a light chain (beta-2 microglobulin). The heavy chain is anchored in the membrane. Class I molecules play a central role in the immune system by presenting peptides derived from the endoplasmic reticulum lumen so that they can be recognized by cytotoxic T cells. They are expressed in nearly all cells. The heavy chain is approximately 45 kDa and its gene contains 8 exons. Exon 1 encodes the leader peptide, exons 2 and 3 encode the alpha1 and alpha2 domains, which both bind the peptide, exon 4 encodes the alpha3 domain, exon 5 encodes the transmembrane region, and exons 6 and 7 encode the cytoplasmic tail. Polymorphisms within exon 2 and exon 3 are responsible for the peptide binding specificity of each class one molecule. Typing for these polymorphisms is routinely done for bone marrow and kidney transplantation. More than 6000 HLA-A alleles have been described. The HLA system plays an important role in the occurrence and outcome of infectious diseases, including those caused by the malaria parasite, the human immunodeficiency virus (HIV), and the severe acute respiratory syndrome coronavirus (SARS-CoV). The structural spike and the nucleocapsid proteins of the novel coronavirus SARS-CoV-2, which causes coronavirus disease 2019 (COVID-19), are reported to contain multiple Class I epitopes with predicted HLA restrictions. Individual HLA genetic variation may help explain different immune responses to a virus across a population.[provided by RefSeq, Aug 2020]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.91).
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.339 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
POLR1HASPENST00000849709.1 linkn.824A>G non_coding_transcript_exon_variant Exon 2 of 2
POLR1HASPENST00000849710.1 linkn.571A>G non_coding_transcript_exon_variant Exon 3 of 3
POLR1HASPENST00000849711.1 linkn.379A>G non_coding_transcript_exon_variant Exon 3 of 3

Frequencies

GnomAD3 genomes
AF:
0.320
AC:
48426
AN:
151540
Hom.:
7962
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.283
Gnomad AMI
AF:
0.356
Gnomad AMR
AF:
0.347
Gnomad ASJ
AF:
0.254
Gnomad EAS
AF:
0.291
Gnomad SAS
AF:
0.219
Gnomad FIN
AF:
0.388
Gnomad MID
AF:
0.288
Gnomad NFE
AF:
0.338
Gnomad OTH
AF:
0.299
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.319
AC:
48443
AN:
151656
Hom.:
7963
Cov.:
31
AF XY:
0.318
AC XY:
23536
AN XY:
74100
show subpopulations
African (AFR)
AF:
0.283
AC:
11640
AN:
41190
American (AMR)
AF:
0.347
AC:
5289
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.254
AC:
880
AN:
3468
East Asian (EAS)
AF:
0.292
AC:
1506
AN:
5166
South Asian (SAS)
AF:
0.218
AC:
1050
AN:
4816
European-Finnish (FIN)
AF:
0.388
AC:
4081
AN:
10518
Middle Eastern (MID)
AF:
0.282
AC:
83
AN:
294
European-Non Finnish (NFE)
AF:
0.338
AC:
22971
AN:
67948
Other (OTH)
AF:
0.295
AC:
619
AN:
2098
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.515
Heterozygous variant carriers
0
1673
3346
5019
6692
8365
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
468
936
1404
1872
2340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.328
Hom.:
5550
Bravo
AF:
0.316
Asia WGS
AF:
0.230
AC:
799
AN:
3470

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.91
CADD
Benign
3.2
DANN
Benign
0.34
PhyloP100
-0.37

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2517715; hg19: chr6-29917439; API